advertisement
11.20 Other (8)
Showing records 1 to 8
Display all abstracts in classification 11.20 Other
Search within classification 11.20 Other
60077 Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover studyTanihara H
Acta Ophthalmologica 2015; 93: e254-e260
60713 Intraocular pressure control with echothiophate iodide in children's eyes with glaucoma after cataract extractionKraus CL
Journal of AAPOS 2015; 19: 116-118.e1
59973 Ripasudil: first global approvalGarnock-Jones KP
Drugs 2014; 74: 2211-2215
60077 Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover studyInoue T
Acta Ophthalmologica 2015; 93: e254-e260
60713 Intraocular pressure control with echothiophate iodide in children's eyes with glaucoma after cataract extractionTrivedi RH
Journal of AAPOS 2015; 19: 116-118.e1
60077 Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover studyYamamoto T
Acta Ophthalmologica 2015; 93: e254-e260
60713 Intraocular pressure control with echothiophate iodide in children's eyes with glaucoma after cataract extractionWilson ME
Journal of AAPOS 2015; 19: 116-118.e1
60077 Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover studyKuwayama Y; Abe H; Suganami H; Araie M;
Acta Ophthalmologica 2015; 93: e254-e260
Issue 16-4
Change Issue
advertisement